UK Life Science Strategy Urges Adoption Of Accelerated Access Review, As Govt Prepares Response

 
• By Ian Schofield
Benefit & Cost
Value assessments are part of the industry's wish-list in UK life science strategy

More from Market Access

More from Pink Sheet